US2013164321A1PendingUtilityA1

Use of antrodia camphorata for treating skin conditions

Assignee: YU CHIEH-CHOUPriority: Jan 19, 2010Filed: Feb 21, 2013Published: Jun 27, 2013
Est. expiryJan 19, 2030(~3.5 yrs left)· nominal 20-yr term from priority
Inventors:Chieh-Chou Yu
A61P 35/00A61P 3/06A61P 9/10A61P 3/10A61P 37/08A61P 9/00A61P 11/00A61K 36/06A61P 19/06A61P 17/00A61P 17/10A61K 9/0053A61P 11/02A61K 36/07
39
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to the use of antrodia camphorata in the treatment of skin conditions, such as acne vulgaris, urticaria and eczema, allergic rhinitis, diabetes mellitus and its complications, cancer cachexia, hypercholesterolemia, gout in a subject in need of such treatment. The present invention is also directed to the use of antrodia camphorata in the prevention and treatment of oral cancer and arterial restenosis, in a subject in need of such prevention. The methods comprise the steps of: identifying a subject in need thereof, and administering to the subject a formulation comprising an effective amount of antrodia camphorata, whereby the symptoms in the subject are reduced or prevented. The composition can be a pharmaceutical composition or a nutraceutical composition.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for treating a skin condition in a subject, the method comprising the administering of a composition comprising an effective amount of antrodia camphorate, hereby the symptoms and signs of the skin condition are reduced. 
     
     
         2 . The method according to  claim 1 , wherein said skin condition is selected from the group consisting of acne vulgaris, eczema, and urticaria. 
     
     
         3 . The method according to  claim 1 , wherein said composition comprises about 1-8 g of dry weight of antrodia camphorata. 
     
     
         4 . The method according to  claim 3 , wherein said composition comprises about 4 g of dry weight of antrodia camphorata. 
     
     
         5 . The method according to  claim 1 , wherein said composition is a pharmaceutical composition. 
     
     
         6 . The method according to  claim 1 , wherein said composition is a nutraceutical composition. 
     
     
         7 . The method according to  claim 1 , wherein the said administering is oral administration.

Join the waitlist — get patent alerts

Track US2013164321A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.